Most medical devices never undergo rigorous safety testing before hitting the market. Instead, they are cleared through the FDA's 510(k) pathway, which allows devices to be approved if they are deemed substantially equivalent to an existing 'predicate' device. But similar is not the same as safe, and that gap can lead to recalls down the line.
A new study suggests artificial intelligence could help close that gap. The research estimates that AI could cut medical device recalls by nearly a third, potentially flagging design or performance problems that might otherwise go unnoticed until after a device is already in use.
The study highlights a core weakness in the current approval system: relying on predicate devices can perpetuate flaws rather than catch them. While the article does not detail how the AI would be implemented, it points to the technology's potential to strengthen oversight and improve patient safety without overhauling the entire regulatory framework.